Early Diagnosis of Breast Cancer: Public Health and Mammographic Screening by unknown
Early Diagnosis of Breast Cancer: Public Health
and Mammographic Screening
Rinat Gamirov1,4 & Ludmila Komarova2 & Rustem Khasanov3 & Regina Gamirova5
Published online: 18 January 2018
# Springer Science+Business Media, LLC, part of Springer Nature 2018
Abstract
Malignant breast tumors are the leading oncological pathology (after skin cancer) in the female population all over the world (more
than 20%). According to American Cancer Society, breast cancer is expected to account for 30% of all new cancer cases among
women in 2017 (Simon, 2017). The research in the sphere of the timely diagnosis of malignant neoplasms led to the development
and further widespread implementation of screening programs, which help to reveal the disease before the onset of symptoms or
signs of illness. The paper discusses different scientific approaches to mass screening, various opinions concerning the real impact
of screening and contemporary treatment into breast cancer mortality decrease, and presents the results of a breast screening
program in the Republic of Tatarstan (Russian Federation). The results showed the effectiveness of this diagnostic method: in
59,000 women aged 50–69 years in total, there were revealed 373 cases of breast cancer (0.63%), in which breast cancer of the I–II
stage was 80%. Of the histological forms, 45.4% in the detected malignant neoplasms were presented by invasive ductal cancer,
24.8%—by invasive lobular carcinoma, and the proportion of non-invasive cancer was 4%. Cancer without metastatic involve-
ment of lymphatic nodes (T1–4N0) occurred in 63% of cases. The paper discusses such negative factors of mass mammographic
screening as overdiagnosis, false-positive results, and overtreatment. The analyses of existing research all over the world show that
since the problem has been actively studied all over the world, the approach to the analysis of screening results has changed to the
prevalence of individual approach to each case, the number of cases connected with overdiagnosis is constantly reduced, and the
quality of visualization is rapidly improving due to the success of interdisciplinary research and rapid technical progress.
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1 Introduction
Malignant breast tumors are the leading oncological patholo-
gy (after skin cancer) in the female population all over the
world (more than 20%). The research in the sphere of the
timely diagnosis of malignant neoplasms led to the develop-
ment and further widespread implementation of screening
programs, which help to reveal the disease before the onset
of symptoms or signs of illness. In the 1960s and 1980s, the
population screening began to be practiced in the USA and a
number of European countries. So, several decades have
passed since the first screening programs for breast cancer
by means of mammography. The effectiveness of this method
as the main test in screening programs has been tested in many
randomized trials conducted around the world. The wide de-
velopment of screening programs in various countries of the
world contributed to solving one of the main tasks in oncolo-
gy—reducing the mortality from breast cancer.
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